Get the Stockscreener App
93.73
1.08%
-1.02
Pre-market:
94.00
0.27
+0.29%
Ishares U S Pharmaceuticals Etf stock is traded at $93.73, with a volume of 117.15K.
It is down -1.08% in the last 24 hours and up +6.71% over the past month.
See More
Previous Close:
$94.75
Open:
$94.72
24h Volume:
117.15K
Relative Volume:
1.35
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.23%
1M Performance:
+6.71%
6M Performance:
+8.89%
1Y Performance:
+38.86%
1-Day Range:
$93.41
$94.72
1-Week Range:
$92.94
$95.60
52-Week Range:
$64.46
$95.60
Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Name
Ishares U S Pharmaceuticals Etf
Sector
Industry
Phone
-
Address
-
Compare IHE vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IHE
Ishares U S Pharmaceuticals Etf
|
93.73 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
372.53 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
754.83 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
756.35 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
298.44 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
744.00 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares U S Pharmaceuticals Etf Stock (IHE) Latest News
iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns - AOL.com
Ditch or double down on this pharma ETF as Trump adjusts drug prices? - MSN
Even if Eli Lilly stock continues to shine, stay away from this pharmaceutical ETF - MSN
Trump Administration Prepares Up To 100% Pharma Tariffs On Drugs From Companies That Have Not Struck A Deal Yet: Report - Stocktwits
Healthcare ETFs: From Broad Exposure to Big Breakthroughs - ETF Database
The iShares U.S. Pharmaceutical ETF Has Achieved a Return of Over 42% in the Past Year - NAI500
iShares vs Simplify Health Care ETFs: A Comparison of Two Healthcare Funds - IndexBox
iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns - The Motley Fool
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - TradingView
IXUS vs. IEFA: Which International ETF Is Better for Most Investors? - The Motley Fool
Middle East Erupts Again: Buy these Healthcare ETFs Before the Next Strike - The Globe and Mail
Pharma stocks are showing strength. Charts predict this name could break out next - CNBC
iShares MSCI World ETF Faces a Crucible of Rate Fears, a Dividend Date, and a Landmark Space IPO - AD HOC NEWS
Sector Update: Healthcare - Moomoo
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance
Flow Focus | Marvell Ripped, Broadcom Cracked — AI Money Is Getting Pickier - Moomoo
MSCI World ETF Caught Between a Mega-IPO and a Narrowing Market - AD HOC NEWS
The Technical Signals Behind (IHE) That Institutions Follow - Stock Traders Daily
iShares MSCI World ETF Faces a Congested June Calendar: Dividend, Fed Decision, and Tariff Fallout - AD HOC NEWS
The $12 Billion Index Mechanic: Why the MSCI World ETF Cannot Dodge SpaceX’s Mega-IPO - AD HOC NEWS
MACD Signal Flashes Bullish for MSCI World ETF, but Pharma Tariffs and SpaceX Add to the Risk Stack - AD HOC NEWS
ETF Diversification and IHE Analysis - asatunews.co.id
The iShares MSCI World ETF: A Record High Surrounded by a Thicket of Risks - AD HOC NEWS
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Yahoo Finance
Adding a Healthcare Stock to Your Portfolio? FHLC Offers Broad Coverage While PPH Leads in Returns. - AOL.com
Even If Eli Lilly Stock Continues to Shine, Stay Away from This Pharmaceutical ETF - Yahoo Finance
GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game. - AOL.com
Sector Update: Healthcare Stocks Down Premarket Tuesday - Moomoo
These 2 Dividend ETFs Are Beating the S&P 500 -- Which Should You Buy? - The Motley Fool
iShares MSCI World ETF Hits Record High Amid Index Reshuffle and Pharma Tariff Headwinds - AD HOC NEWS
Exchange-Traded Funds, Equity Futures Rise Pre-Bell Friday Amid US-Iran Deal Hopes - Moomoo
Healthcare ETFs to Buy as Eli Lily Steps Into Vaccine Market With $4B Bet - TradingView
7 Best Socially Responsible Funds | InvestingU.S. News - U.S. News - Money
PPH vs. IXJ: A Pure Pharma Bet Against the Entire Global Healthcare Ecosystem - The Motley Fool
Precision Trading with Ishares U.s. Pharmaceuticals Etf (IHE) Risk Zones - Stock Traders Daily
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - Yahoo Finance
iShares U.S. Pharmaceuticals ETF outperforms despite drug pricing policy risks, up 38% in 12 months. - Pluang
Ditch or Double Down on This Pharma ETF as Trump Adjusts Drug Prices? - Yahoo Finance
Should you invest in the iShares US Pharmaceuticals ETF (IHE)? - MSN
Healthcare sector undervalued, with iShares U.S. Pharmaceuticals ETF leading gains but risks from concentration exist. - Pluang
IHE: Healthcare Dashboard For May - Seeking Alpha
The Silver Tsunami: Healthcare ETFs to Buy Amid Aging US Demographics - The Globe and Mail
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Ishares U S Pharmaceuticals Etf Stock (IHE) Financials Data
There is no financial data for Ishares U S Pharmaceuticals Etf (IHE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.53%
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):